Corponi, Filippo http://orcid.org/0000-0002-6807-0617
Li, Bryan M. http://orcid.org/0000-0003-3144-4838
Anmella, Gerard http://orcid.org/0000-0002-6798-4054
Mas, Ariadna
Pacchiarotti, Isabella
Valentí, Marc
Grande, Iria http://orcid.org/0000-0002-0137-0666
Benabarre, Antoni
Garriga, Marina
Vieta, Eduard http://orcid.org/0000-0002-0548-0053
Lawrie, Stephen M. http://orcid.org/0000-0002-2444-5675
Whalley, Heather C. http://orcid.org/0000-0002-4505-8869
Hidalgo-Mazzei, Diego http://orcid.org/0000-0002-2693-6849
Vergari, Antonio
Article History
Received: 7 July 2023
Revised: 9 March 2024
Accepted: 13 March 2024
First Online: 26 March 2024
Competing interests
: All authors report no financial or other relationship relevant to the subject of this article. GA has received CME-related honoraria, or consulting fees from Angelini, Casen Recordati, Janssen-Cilag, Lundbeck, Lundbeck/Otsuka, and Rovi, with no financial or other relationship relevant to the subject of this article. IP has received CME-related honoraria, or consulting fees from Janssen-Cilag, Lundbeck, Lundbeck/Otsuka, CASEN Recordati and Angelini, with no financial or other relationship relevant to the subject of this article. MV has received research grants from Eli Lilly & Company and has served as a speaker for Abbott, Bristol–Myers Squibb, GlaxoSmithKline, Janssen–Cilag, and Lundbeck. MG has received CME-related honoraria, or consulting fees from Angelini, Janssen-Cilag, Lundbeck, Lundbeck/Otsuka, and Ferrer, with no financial or other relationship relevant to the subject of this article. EV has received grants and served as consultant, advisor or CME speaker for the following entities: AB-Biotics, AbbVie, Adamed, Angelini, Biogen, Beckley-Psytech, Biohaven, Boehringer-Ingelheim, Celon Pharma, Compass, Dainippon Sumitomo Pharma, Ethypharm, Ferrer, Gedeon Richter, GH Research, Glaxo-Smith Kline, HMNC, Idorsia, Johnson & Johnson, Lundbeck, Luye Pharma, Medincell, Merck, Newron, Novartis, Orion Corporation, Organon, Otsuka, Roche, Rovi, Sage, Sanofi-Aventis, Sunovion, Takeda, Teva, and Viatris, outside the submitted work. DHM has received CME-related honoraria and served as consultant for Abbott, Angelini, Ethypharm Digital Therapy and Janssen-Cilag.
: This study was conducted in accordance with the ethical principles of the Declaration of Helsinki and Good Clinical Practice and the Hospital Clinic Ethics and Research Board (HCB/2021/104). All participants provided written informed consent prior to their inclusion in the study.